跳至主要内容
临床试验/NCT05639777
NCT05639777招募中4 期

The Effect of Intranasal Dexmedetomidine Premedication in Children Undergoing Adenotonsillectomy Suffering From Recent Mild Upper Respiratory Tract Infection

Tanta University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2022年12月6日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
70
试验地点
1
主要终点
The incidence of peri-operative respiratory adverse effects (PRAE).

研究概览

简要总结

The purpose of this study is to detect the efficacy of intranasal dexmedetomidine as a premedication to general anesthesia in pediatric patients with respiratory comorbidities undergoing adenotonsillectomy.

详细描述

Respiratory comorbidities are associated with an increased incidence of peri-operative respiratory adverse effects (PRAE).

Upper and lower respiratory infections, as well as asthma, are common in children who are scheduled for adenotonsillectomy. When compared to healthy children, children with respiratory ailments have a three-fold increase in PRAEs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
3 Years 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children with recent mild URI or asthma.
  • aged from 3 to 10 years
  • ASA Physical Status II,
  • undergoing adenotonsillectomy

排除标准

  • Parental refusal of participation
  • Evidence of moderate to severe upper respiratory tract infection at time of presentation on the day of surgery
  • Lower respiratory tract infection
  • Congenital heart diseases
  • Known hypersensitivity to specific anesthetic agent
  • Liver or renal disease

研究组 & 干预措施

Intranasal

Experimental

That will receive intranasal dexmedetomidine (1.5mcg/kg)

干预措施: Dexmedetomidine group (Drug)

control group

Placebo Comparator

That will receive the same volume of 2 ml of intranasal normal saline

干预措施: control group (Other)

结局指标

主要结局

The incidence of peri-operative respiratory adverse effects (PRAE).

时间窗: From induction to emergence from general anesthesia.

All PRAE and the time of occurrence (induction, maintenance or emergence) will be recorded.

次要结局

  • Hemodynamic stability(15 and 30 min after sedation)
  • Sedating effects of this drug.(15 and 30 min after sedation)
  • Ease of parental separation.(15 and 30 min after sedation)
  • Face mask acceptance.(15 and 30 min after sedation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eman Ahmed Azzam

Resident of Anesthesia, Surgical Intensive Care and Pain Mrdicine

Tanta University

研究点 (1)

Loading locations...

相似试验